Track the Kane Biotech Inc. share price and the full management transaction log of the company, a publicly traded company based in Canada. Shares trade on CA CA, under the authority of SEDI. Operating in the Health Care sector, Kane Biotech Inc. has published 16 public disclosures. Market capitalisation: €6.2m. The latest transaction was filed on 6 July 2026 (50 - Grant of options). Among the most active insiders: Renaud, Philip. The full history is openly available.
16
Insider Decl.
n/a
Thresholds
n/a
n/a
Buy Volume
n/a
n/a
Sell Volume
34Σ signal
This score ranks the purchase within its own market. No market currently meets the historical allocation criteria, so signals remain watch-only. Not investment advice.
Σ
Sigma AI Analysis
Fundamental view, insider signal, bull and bear case, synthesis.
AI-generated analysis. Opinion, not investment advice. Not backtested. Built from public filings and financials. No price target, no buy or sell recommendation.
20,000,000 shares@ CA$0.0545.5% of flowCommon SharesTSXSEDI:4724810
Canonical exit: 23 Aug 2026 (T+90)
16 of 16 declarations
About Kane Biotech Inc.
Kane Biotech Inc. is a biotechnology company focused on developing solutions to prevent and treat infections caused by biofilms. It is listed on the XTSE.